Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Bio-Rad Laboratories Inc. (BIO)

274.26   -0.08 (-0.03%) 02-22 16:02
Open: 275.35 Pre. Close: 274.34
High: 275.71 Low: 271.7
Volume: 247,546 Market Cap: 8158M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 276.033 - 277.487 277.487 - 278.724
Low: 268.222 - 269.886 269.886 - 271.301
Close: 271.179 - 274.002 274.002 - 276.403

Technical analysis

as of: 2019-02-22 4:40:23 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 322.13     One year: 376.25
Support: Support1: 249.46    Support2: 233.18
Resistance: Resistance1: 275.80    Resistance2: 322.13
Pivot: 259.81
Moving Average: MA(5): 272.28     MA(20): 255.49
MA(100): 260.92     MA(250): 277.10
MACD: MACD(12,26): 8.19     Signal(9): 5.86
Stochastic oscillator: %K(14,3): 96.10     %D(3): 97.66
RSI: RSI(14): 76.47
52-week: High: 345.15  Low: 220.05  Change(%): 7.7
Average Vol(K): 3-Month: 22350  10-Days: 28460

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
BIO has closed below upper band by 13.7%. Bollinger Bands are 34% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 21 Feb 2019 18:19:22 Z
Bio-Rad Laboratories (BIO) Reports Next Week: Wall Street Expects Earnings Growth

Thu, 21 Feb 2019 16:24:27 Z
Will Difficult Comparison Hurt Bio-Rad's (BIO) Q4 Earnings?

Sun, 03 Feb 2019 23:06:27 Z
Validea's Top Five Technology Stocks Based On David Dreman - 2/3/2019

Thu, 03 Jan 2019 15:13:07 Z
Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M

Mon, 31 Dec 2018 15:08:16 Z
Analysts See 33% Gains Ahead For The Holdings of EQAL

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 29.96
Shares Float (M) 24.72
% Held by Insiders
% Held by Institutions 84.30
Shares Short (K) 537
Shares Short P. Month (K)

Stock Financials

EPS 5.220
EPS Est. Current Year 2.710
EPS Est. Next Year 4.500
EPS Est. Next Quarter 1.730
Forward EPS 7.410
Book Value (p.s.) 1.580
PEG Ratio 1.28
Profit Margin 71.40
Operating Margin 8.73
Return on Assets (ttm) 23.5
Return on Equity (ttm) 33.1
Qtrly Rev. Growth 2.1
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 1120.50
Operating Cash Flow (M) 249.60
Levered Free Cash Flow (M) 169.14

Stock Valuations

P/E 52.47
P/E Growth Ratio
P/BV 173.36
P/S 88479768.00
P/CF 32.88

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.